-
EHDS stakeholder meeting with EU officials
September 6, 20236 September 2023, Brussels – PIONEER as part of a multi-stakeholder group consisting of 32 European patient organisations, medical...
0 -
PIONEER and the Chinese University of Hong Kong Started a Big Data Collaboration to Fight Prostate Cancer Worldwide
August 22, 2023The European funded prostate cancer project PIONEER – Big Data in Prostate Cancer and the Faculty of Medicine of...
-
Joint Statement: health organisations define EHDS’ opt out required for life saving research
June 6, 2023On 6 June, PIONEER joined together with 31 other health stakeholders to share views on specific recommendations for a...
-
Stakeholders’ consensus response to the proposed European Health Data Space
October 20, 2022On 20 October, PIONEER joined a group of 29 stakeholders in welcoming the European Commission’s proposal on the European...
-
Latest Interviews with the Patient-reported Outcome Measures & Core Outcome Set Working Groups
July 12, 2022Catch up on all the developments related to the PIONEER patient-related outcome measures and core outcome set working groups....
-
Press release: SAS deploys SAS Viya in the central PIONEER Big Data Platform for Prostate Cancer
May 3, 2022PIONEER: The International Network of Excellence for Big Data in Prostate Cancer announces that consortium partner SAS has deployed...
-
PIONEER Diagnostic and Prognostic Online Search Tool Launched
April 14, 2022Multiple diagnostic & prognostic biomarkers are available to improve prostate cancer diagnosis and prognosis. However, knowledge on which diagnostic...
-
PIONEER publishes Core Outcome Sets for Prostate Cancer
February 17, 2022PIONEER: The International Network of Excellence for Big Data in Prostate Cancer announces the release of their core outcome...
-
Call to action: PIONEER Patient Related Outcome Measures
August 12, 2021Prostate Cancer (PCa) is characterised by a relatively long natural history, where a substantial proportion of PCa patients die...
-
Press release: Paving the way for machine learning with medical data
July 27, 2021Data science specialist CASUS and the PIONEER research consortium ally in the fight against prostate cancer The Centre for...
Contact us here
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
